Investor Sues To Halt Genstar's $400M Buy Of Research Co.
An eResearch Technology Inc. shareholder moved Wednesday to block Genstar Capital LLC's $400 million bid for the biopharmaceutical research provider with a class action alleging the offer is inadequate and tainted...To view the full article, register now.
Already a subscriber? Click here to view full article